Daily Archives: October 14, 2021 | LinksMedicus Free Medical News & Perspectives

How to be a good science communicator.

14 Oct, 2021 | 10:13h | UTC

How to be a good science communicator – Nature Medicine

Commentary on Twitter

During the COVID-19 pandemic, the public have turned to scientists and doctors for vital information. But science communication is a skill in itself, so we asked the experts to share their tips.

Feature from @polkajunction https://t.co/eK2HYqs67m

— Nature Medicine (@NatureMedicine) October 13, 2021

Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.

14 Oct, 2021 | 10:15h | UTC

Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review – JAMA Network Open

Commentaries:

Most COVID-19 survivors have symptoms 6 months on, review finds – CIDRAP

Expert reaction to systematic review on rates of postacute sequelae of SARS-CoV-2 infection (PASC) – Science Media Centre

How many people get ‘long COVID’? More than half, researchers find – Penn State

WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).

Characterizing long COVID: a living systematic review.

Long Covid – The illness narratives.

New guidelines to help doctors manage long COVID patients published.

M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)

Commentary on Twitter

Most #COVID19 survivors have symptoms 6 months on, review finds

Data on more than 250,000 survivors reveal 54% had at least 1 symptom 6 months or more after diagnosis #LongCovid https://t.co/xd0lvhQFfL pic.twitter.com/65mqe7SQPg

— CIDRAP (@CIDRAP) October 13, 2021

Video: Merck’s Covid pill could transform treatment. Here’s how it works.

14 Oct, 2021 | 10:10h | UTC

Watch: Merck’s Covid pill could transform treatment. Here’s how it works – STAT

How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.

What we know — and don’t know — about Merck’s new Covid-19 pill.

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.

[Preprint] In RCT with 29,949 participants, the Novavax vaccine demonstrated high overall efficacy (>90%) for the prevention of Covid-19, and all moderate-to-severe cases occurred in placebo recipients.

14 Oct, 2021 | 10:17h | UTC

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico – medRxiv

Commentary: Novel vaccine demonstrates high efficacy for prevention of COVID-19 – News Medical

RCT: Novavax vaccine conferred 89.7% protection against symptomatic SARS-CoV-2 infection and 100% protection against hospitalizations or deaths.

Opinion | The mRNA vaccines are extraordinary, but Novavax is even better.

(Press release – not published yet) Novavax COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease.

RCT: Novavax vaccine is 49.4% effective against B.1.351 SARS-CoV-2 variant.

[Press release – not published yet] Novavax reports 96% efficacy against original strain of COVID-19, 86% efficacy against B.1.1.7 variant, and 55% efficacy against B1.351 variant

New COVID-19 vaccines: here’s how the promising Novavax and Johnson & Johnson jabs work

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant

Commentary on Twitter

Remember Novavax's #COVID vaccine?

Recent data looks really good.

~30K participants enrolled in a prospective clinical trial.

The vaccine appeared to be safe & effective (>90%).

Unclear why approval is taking so long.

Preprint ? https://t.co/MQkJXdgJyR pic.twitter.com/217Erw2stC

— Isaac Bogoch (@BogochIsaac) October 12, 2021

WHO provides guidance to address the shortage of quality palliative care services.

14 Oct, 2021 | 09:59h | UTC

News release: WHO takes steps to address glaring shortage of quality palliative care services – World Health Organization

See Guidance:

Assessing the development of palliative care worldwide: a set of actionable indicators – World Health Organization

Quality health services and palliative care: practical approaches and resources to support policy, strategy and practice – World Health Organization

Commentary on Twitter (thread – click for more)

Today is World Hospice and Palliative Care Day!

DYK❓ Over 5⃣5⃣ million people around the ? are in need of #PalliativeCare but only 12% of the global need is met.

Access to palliative care services is a human right to health ?https://t.co/MebmzEstql pic.twitter.com/WQ3d40dH6d

— World Health Organization (WHO) (@WHO) October 9, 2021

How Covax failed on its promise to vaccinate the world – “Covax, described as “naively ambitious” by one expert, has contributed just 5% of all vaccines administered globally”.

14 Oct, 2021 | 10:12h | UTC

How Covax failed on its promise to vaccinate the world – The Bureau of Investigative Journalism

Perspective | A beautiful idea: how COVAX has fallen short.

WHO Launches Strategy to Achieve Global Covid-19 Vaccination by mid-2022.

WHO special envoys: To beat Covid, there’s a simple lesson – no one’s safe until everyone’s safe.

Joint COVAX Statement on the Equal Recognition of Vaccines – COVAX urges all government authorities to recognize as fully vaccinated all people who have received COVID-19 vaccines that have been deemed safe and effective by WHO.

WHO COVAX Joint Statement: Call to action to equip COVAX to deliver 2 billion doses in 2021.

Covax: How will Covid vaccines be shared around the world?

Home Hemodialysis: Core Curriculum 2021.

14 Oct, 2021 | 09:55h | UTC

Home Hemodialysis: Core Curriculum 2021 – American Journal of Kidney Diseases

Commentary on Twitter

Nephrologists and dialysis providers must embrace new technologies and improve their understanding of home hemodialysis systems. Review the benefits, pitfalls, and challenges of HHD in this Core Curriculum by @ScottDBieber and Bessie Young:https://t.co/TAPiH4wSIA (FREE) pic.twitter.com/dgeX0XKiuL

— AJKD (@AJKDonline) October 5, 2021

ASH 2021 guidelines for stem cell transplantation in patients with sickle cell disease.

14 Oct, 2021 | 09:53h | UTC

American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation – Blood

News release: ASH Releases New Clinical Practice Guidelines on Stem Cell Transplantation in Sickle Cell Disease

Commentary: ASH Issues Guideline on the Use of HSCT for Sickle Cell Disease – HealthDay

Podcast with Dr Walter Willett: CardioNutrition – Why are findings from prospective, epidemiologic cohort studies important in informing dietary recommendations?

14 Oct, 2021 | 09:49h | UTC

ACC CardiaCast: CardioNutrition – Why Are Findings From Prospective, Epidemiologic Cohort Studies Important In Informing Dietary Recommendations? – American College of Cardiology

Commentary on Twitter

In this episode of CardioNutrition, @DrOstfeld and Dr. Walter Willett discuss why findings from prospective, epidemiologic cohort studies are important in informing dietary recommendations. Learn more here: https://t.co/IfIgauGhV9 #cvPrev #cvLipids pic.twitter.com/flet8ZTwFe

— American College of Cardiology (@ACCinTouch) October 8, 2021